(Q51069073)

28 March 2018

title

Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. (English)

1 reference

28 March 2018

Abdallah Alzoubi

1

0 references

author name string

Michie Toba

2

1 reference

28 March 2018

Kohtaro Abe

3

1 reference

28 March 2018

Kealan D O'Neill

4

1 reference

28 March 2018

Petra Rocic

5

1 reference

28 March 2018

Karen A Fagan

6

1 reference

28 March 2018

Ivan F McMurtry

7

1 reference

28 March 2018

Masahiko Oka

8

1 reference

28 March 2018

publication date

12 April 2013

1 reference

28 March 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

28 March 2018

volume

304

1 reference

28 March 2018

issue

12

1 reference

28 March 2018

page(s)

H1708-18

1 reference

28 March 2018

Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Oxidative stress in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Pathogenic mechanisms of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Increased Rho kinase activity in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Tricuspid annular displacement predicts survival in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

The monocrotaline model of pulmonary hypertension in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Peroxynitrite mediates right-ventricular dysfunction in nitric oxide-exposed juvenile rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Activation of NADPH oxidase during progression of cardiac hypertrophy to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Rho kinase-mediated vasoconstriction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology,

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Lucigenin chemiluminescence assay as an adjunctive tool for assessment of various stages of inflammation: a study of quiescent inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

The biological actions of dehydroepiandrosterone involves multiple receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2012

10.1152/AJPHEART.00746.2012

21 January 2018

Identifiers

DOI

1 reference

28 March 2018

PubMed ID

23585128

1 reference

28 March 2018